1989PubMedRequires access

Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotence.

Siraj Qh, M A Akhtar

Open publisher page 3 citations

Abstract

This study details our initial experience with pharmacologically induced penile erections in the diagnosis and therapy of patients with impotence. Intracavernosal injections of papaverine were performed in 5 normal volunteers, 5 patients with psychogenic impotence and 2 patients with penile venous incompetence. The patients were first investigated extensively to determine the etiological basis for their erectile dysfunction. It was observed that the patients with psychogenic impotence and the normal volunteers showed a good response whereas the patients with venous incompetence failed to achieve erection in response to intracavernosal injection. A new drug, Prostaglandin E1 was also tried for the first time for comparison. It appears that this drug has potential advantages over the currently used agent papaverine for the production of pharmacological erections.

About this research paper

What this paper is about

This study details our initial experience with pharmacologically induced penile erections in the diagnosis and therapy of patients with impotence. Intracavernosal injections of papaverine were performed in 5 normal volunteers, 5 patients with psychogenic impotence and 2 patients with penile venous incompetence. The patients were first investigated extensively to determine the etiological basis for their erectile dysfunction. It was observed that the patients with psychogenic impotence and the normal volunteers showed a good response whereas the patients with venous incompetence failed to achieve erection in response to intracavernosal injection. A new drug, Prostaglandin E1 was also tried for the first time for comparison. It appears that this drug has potential advantages over the currently used agent papaverine for the production of pharmacological erections.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This study details our initial experience with pharmacologically induced penile erections in the diagnosis and therapy of patients with impotence. Intracavernosal injections of papaverine were performed in 5 normal volunteers, 5 patients with psychogenic impotence and 2 patients with penile venous incompetence. The patients were first investigated extensively to determine the etiological basis for their erectile dysfunction. It was observed that the patients with psychogenic impotence and the normal volunteers showed a good response whereas the patients with venous incompetence failed to achieve erection in response to intracavernosal injection. A new drug, Prostaglandin E1 was also tried for the first time for comparison. It appears that this drug has potential advantages over the currently used agent papaverine for the production of pharmacological erections.

Key concepts: Medicine, Papaverine, Psychogenic disease, Prostaglandin E1, Erectile dysfunction, Penis, Etiology, Priapism

Related papers

Back to paper searchBrowse research topicsOriginal source
Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotence. — Research Paper | ScholarLens